News & Blogs
Blog
Recent Posts
iCura Diagnostics’ Commitment to Developing Reliable, Affordable, and Easy-to-Use Covid-19 Diagnostic Kits
Advancing Clinical Trials and Medical Diagnoses with FDA-Approved Circulating Tumor Cell (CTC) Services
Introducing Our Validated 6-Plex 7-Color Lung Cancer and Melanoma Panel: Precision Diagnostics Redefined
Transforming Clinical Trial Studies with iCura’s Validated Digital Pathology Services: Multiplexing IF/IHC, Image Analysis, and More
Our full line of Digital Pathology Services is built on industry-leading digital pathology solution platforms that are fully validated for Clinical Trial...
Latest Blog
iCura Diagnostics Certified as Fully Qualified Service Provider Partner by AKOYA Biosciences
iCura Diagnostics Certified as Fully Qualified Service Provider Partner by AKOYA Biosciences We
Transforming Clinical Trial Studies with iCura’s Validated Digital Pathology Services: Multiplexing IF/IHC, Image Analysis, and More
Our full line of Digital Pathology Services is built on industry-leading digital pathology
Elevating Oncologic Studies with State-of-the-Art Next Generation Sequencing (NGS) and Digital PCR Platforms
iCura Diagnostics is proud to offer advanced Next Generation Sequencing (NGS) and Digital
Introducing Our Validated 6-Plex 7-Color Lung Cancer and Melanoma Panel: Precision Diagnostics Redefined
Introducing Our Validated 6-Plex 7-Color Lung Cancer and Melanoma Panel: Precision Diagnostics Redefined
Advancing Clinical Trials and Medical Diagnoses with FDA-Approved Circulating Tumor Cell (CTC) Services
Advancing Clinical Trials and Medical Diagnoses with FDA-Approved Circulating Tumor Cell (CTC) Services
iCura Diagnostics’ Commitment to Developing Reliable, Affordable, and Easy-to-Use Covid-19 Diagnostic Kits
We are intensively working on development of Covid-19 diagnostic kits to provide reliable,